Skip to main content

IL-1 beta receptor antagonist efficacy in the treatment of idiopathic recurrent pericarditis

Objective

To assess the efficacy of IL-1 beta receptor antagonist (IL-1RA) in the treatment of steroid dependent idiopathic recurrent pericarditis (RP).

Methods

Three patients (1 male, 2 females, aged between 13 and 16) were enrolled. RP was defined by "pericardial" pain and ≥1 of the following signs: fever, pericardial friction rub, electrocardiographic changes, echocardiographic evidence of pericardial effusion, elevated acute phase reactants.

Patients showed recurrent flares of pericarditis with malaise, precordial pain, tachyorthopnoea, sometimes fever. 2/3 developed a life-threatening cardiac tamponade needing pericardiotomy. None of them presented signs or symptoms consistent with a chronic rheumatic disease: antinuclear, anti-coxsackie and anti adenovirus antibodies were negative. Genetic analysis ruled out Familial Mediterranean Fever. Mean disease duration was 2 years and mean rate of recurrences was 4 yearly. Pericarditis seemed steroid dependent and poorly responsive to colchicine.

Results

IL-1RA administration was associated with a dramatic disappearance of symptoms and normalization of acute phase reactants. In all three patients IL-1RA was stopped after the achievement of a complete remission. In all cases, withdrawal was followed by a flare after a few weeks. The reinstitution of IL-1RA was associated with a new immediate response. All patients were mantained on IL-1RA treatment whilst steroids were tapered and stopped; at a mean follow-up of 4 months, none of them has experienced a disease relapse.

Conclusion

IL1-RA may be effective in the treatment of idiopathic recurrent pericarditis; moreover, this preliminary finding seems to suggest that these patients could be affected by a new, not yet identified, genetic autoinflammatory disease.

Author information

Affiliations

Authors

Corresponding author

Correspondence to A Parodi.

Rights and permissions

Open Access This article is published under license to BioMed Central Ltd. This is an Open Access article is distributed under the terms of the Creative Commons Attribution License ( https://creativecommons.org/licenses/by/2.0 ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Reprints and Permissions

About this article

Cite this article

Picco, P., Traverso, F., Brisca, G. et al. IL-1 beta receptor antagonist efficacy in the treatment of idiopathic recurrent pericarditis. Pediatr Rheumatol 6, P126 (2008). https://doi.org/10.1186/1546-0096-6-S1-P126

Download citation

Keywords

  • Familial Mediterranean Fever
  • Pericardial Effusion
  • Pericarditis
  • Cardiac Tamponade
  • Acute Phase Reactant